Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Melanoma 6Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Diarrhea 3Colitis 3Urogenital Neoplasms 2Solid Carcinoma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Mesothelioma 1Lymphoma, Non-Hodgkin 1

Interventions

lorlatinib 3pembrolizumab 2osimertinib 2Radiotherapy 2atezolizumab 1Temozolomide 1Radiosurgery 1Paclitaxel 1Nivolumab 1Ipilimumab 1Fecal Microbiota Transplantation 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Non Small Cell Lung Cancer Metastatic × Fecal Microbiota Transplantation × Clear all
NCT04951583 2024-08-07

FMT-LUMINATE

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Active not recruiting
45 enrolled
DermatologicThoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡